PACE: cluster randomised controlled trial on ‘PACE Steps to Success' palliative care programme in Long Term Care Facilities in Europe

Conditions

Older people living in long term care facilities Not Applicable

Rose Miranda, Tinne Smets, Nele Van Den Noortgate, Jenny T. van der Steen, Luc Deliëns et al. (13 authors)

BMC Palliative Care2021-03-0710 citations

Decreased costs and retained QoL due to the ‘PACE Steps to Success’ intervention in LTCFs: cost-effectiveness analysis of a randomized controlled trial

Anne Wichmann, Eddy Adang, Kris Vissers, Katarzyna Szczerbińska, Marika Kylänen et al. (47 authors)

BMC Medicine2020-09-228 citations

10.1186/s12916-020-01720-9

Lack of Effect of a Multicomponent Palliative Care Program for Nursing Home Residents on Hospital Use in the Last Month of Life and on Place of Death: A Secondary Analysis of a Multicountry Cluster Randomized Control Trial.

Honinx E, Smets T, Piers R, Pasman HRW, Payne SA, Szczerbińska K, Gambassi G, Kylänen M, Pautex S, Deliens L, Van den Block L.

2020-07-065 citations

10.1016/j.jamda.2020.05.003

Decreased costs and retained QoL due to the ‘PACE Steps to Success’ intervention in LTCFs: cost-effectiveness analysis of a randomized controlled trial

Anne Wichmann, Eddy Adang, Kris Vissers, Katarzyna Szczerbińska, Marika Kylänen et al. (13 authors)

Lancaster EPrints (Lancaster University)2020-01-011 citations

10.6084/m9.figshare.c.5128509

Evaluating the implementation of the PACE Steps to Success Programme in long-term care facilities in seven countries according to the RE-AIM framework.

Oosterveld-Vlug M, Onwuteaka-Philipsen B, Ten Koppel M, van Hout H, Smets T, Pivodic L, Tanghe M, Van Den Noortgate N, Hockley J, Payne S, Moore DC, Kijowska V, Szczerbińska K, Kylänen M, Leppäaho S, Mercuri C, Rossi P, Mercuri M, Gambassi G, Bassal C, de Paula EM, Engels Y, Deliens L, Van den Block L, Pasman HR, PACE trial group.

2019-12-1926 citations

10.1186/s13012-019-0953-8

Evaluation of a Palliative Care Program for Nursing Homes in 7 Countries

Lieve Van den Block, Elisabeth Honinx, Lara Pivodic, Rose Miranda, Bregje D. Onwuteaka‐Philipsen et al. (25 authors)

JAMA Internal Medicine2019-11-11106 citations

10.1001/jamainternmed.2019.5349

Integrating palliative care in long-term care facilities across Europe (PACE): protocol of a cluster randomized controlled trial of the 'PACE Steps to Success' intervention in seven countries.

Smets T, Onwuteaka-Philipsen BBD, Miranda R, Pivodic L, Tanghe M, van Hout H, Pasman RHRW, Oosterveld-Vlug M, Piers R, Van Den Noortgate N, Wichmann AB, Engels Y, Vernooij-Dassen M, Hockley J, Froggatt K, Payne S, Szczerbińska K, Kylänen M, Leppäaho S, Barańska I, Gambassi G, Pautex S, Bassal C, Deliens L, Van den Block L, PACE trial group.

2018-03-1231 citations

10.1186/s12904-018-0297-1

Interventions

In each country, six of 12 LTCFs will be randomized to the intervention group, in which they will receive the support of a Country Trainer and with the aid of a self-appointed PACE coordinator in the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: To enhance comparability between countries, LTCFs are eligible to be recruited when they fulfil all of the following inclusion criteria: 1. An off-site family physician or GP is responsible for the resident’s medical care. 2. Social and nursing care is provided onsite . 3. Number of beds per facility is at least 30 but does not exceed 100. 4. We strive to include facilities with at least 15 deceased residents in or outside the facility over the last year. If it is not possible to find enough LTCFs that fit this inclusion criterion, facilities should be selected in which the number of deceased residents in the past year is closest to 15. 5. LTCFs from a predefined geographical location (to be determined by the researchers). 6. Each partner lists all LTCFs fitting these inclusion criteria. From this list, only those LTCFs where the Board of Directors (1) expresses explicit motivation to participate in the study and (2) agrees to free time for one PACE coordinator for e.g. 0.5 days per working week, depending on setting, will be included in the study.

Exclusion criteria

Exclusion criteria: Researchers exclude facilities already using a palliative care planning tool e.g. (accredited users of) the Gold Standards Framework, Route to Success, Six Steps to Success, interRAI-PC version or end of life care integrated pathways such as Liverpool Care Pathway; or those facilities where they judge explicit and detailed palliative care guidelines to be available and corresponding high-quality practices to be implemented.

Design outcomes

Primary

Measure	Time frame
1. Quality of dying of the residents is measured using structured after-death questionnaires including validated instruments like EOLD-CAD (End-Of-Life in Dementia - Comfort Assessment in Dying) and QOD-LTC (Quality of Dying in Long-Term Care) at baseline, month 13 and month 17 after the start of the trial period 2. Staff knowledge and attitudes is measured using structured questionnaires including validated instrument like the ECPS (End-of-Life Professional Caregiver Survey), PCS (Palliative Care Survey) and S-EOLC (Self-Efficacy in End-of-Life Care Survey) at baseline and month 13 after the start of the trial period	—

Measure

Time frame

1. Quality of dying of the residents is measured using structured after-death questionnaires including validated instruments like EOLD-CAD (End-Of-Life in Dementia - Comfort Assessment in Dying) and QOD-LTC (Quality of Dying in Long-Term Care) at baseline, month 13 and month 17 after the start of the trial period 2. Staff knowledge and attitudes is measured using structured questionnaires including validated instrument like the ECPS (End-of-Life Professional Caregiver Survey), PCS (Palliative Care Survey) and S-EOLC (Self-Efficacy in End-of-Life Care Survey) at baseline and month 13 after the start of the trial period

—

Secondary

Measure	Time frame
Quality of palliative care is measured using structured after-death questionnaires including validated instruments like EOLD-SWC (End-Of-Life in Dementia - Satisfaction With Care) and FPPFC (Family Perception of Physician-Family Communication) at baseline, month 13 and month 17 after the start of the trial period.	—

Countries

Belgium, England, Finland, Italy, Netherlands, Poland, Switzerland, United Kingdom

Contacts

Public ContactYuliana Gatsolaeva

yuliana.gatsolaeva@vub.be+32 (0)2 477 49 43

Outcome results

None listed